Bristol-Myers V. Teva: What Doomed The Entecavir Patent
In the unpredictable arts, nonobviousness can sometimes boil down to the existence of unexpected properties in a claimed invention. For a patentee in litigation, it can be important to focus on...To view the full article, register now.
Already a subscriber? Click here to view full article